As previously reported

Adjustments

As restated

Condensed Balance Sheet as of June 30, 2021

Total current liabilities

$

728,371

157,785

886,156

Forward Purchase Agreement

$

2,708,500

12,968,175

15,676,675

Total liabilities

$

71,520,421

13,125,960

84,646,381

Accumulated deficit

$

(69,856,840)

(13,125,960)

(82,982,800)

Total stockholders’ equity (deficit)

$

(69,831,840)

(13,125,960)

(82,957,800)

Condensed Statement of Operations for the three months ended June 30, 2021

Loss from operations

$

(703,215)

(37,772)

(740,987)

Realized and unrealized gains (losses), net

$

27,412,950

(1,738,003)

25,674,947

Total other income (expense)

$

27,427,288

(1,738,003)

25,689,285

Net earnings (loss)

$

26,724,073

(1,775,775)

24,948,298

Basic and diluted net earnings (loss) per Series A common stock

$

—

0.35

Basic and diluted net earnings (loss) per Series F common stock

$

1.86

(1.51)

0.35

Condensed Statement of Operations for the six months ended June 30, 2021

Loss from operations

$

(1,434,303)

(157,785)

(1,592,088)

Realized and unrealized gains (losses), net

$

(17,772,938)

(12,968,175)

(30,741,113)

Total other income (expense)

$

(17,748,517)

(12,968,175)

(30,716,692)

Net earnings (loss)

$

(19,182,820)

(13,125,960)

(32,308,780)

Basic and diluted net earnings (loss) per Series A common stock

$

—

(1.30)

Basic and diluted net earnings (loss) per Series F common stock

$

(1.36)

0.06

(1.30)

Condensed Statement of Cash Flows for the six months ended June 30, 2021

Net earnings (loss)

$

(19,182,820)

(13,125,960)

(32,308,780)

Realized and unrealized (gains) losses, net

$

17,772,938

12,968,175

30,741,113

Changes in accounts payable

$

(390,925)

157,785

(233,140)